Literature DB >> 3082888

The tissue form of type VII collagen is an antiparallel dimer.

N P Morris, D R Keene, R W Glanville, H Bentz, R E Burgeson.   

Abstract

We recently reported the partial characterization of a new human collagen termed Type VII. This molecule is distinctive among the collagen family in that it contains three identical subunit alpha chains within a triple helical domain 424 nm in length. The molecule contains three identical alpha chains which are genetically distinct from other known collagens. Previous studies indicate that a portion of the limited pepsin-solubilized molecules appears to exist as antiparallel dimers associated by disulfide bonds. In this report, we demonstrate that the major tissue form of Type VII collagen is a dimer, associated by disulfide bonds through a 60-nm overlap of the aminoterminal triple helical ends. Intermolecular disulfide bonds occur only within this overlap region. Interchain disulfide bonds exist in the carboxyl terminal 7% of the molecule and may exist within the overlap region as well. Disulfide bond-stabilized aggregates larger than dimers are not seen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082888

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils.

Authors:  M Ryynänen; J Ryynänen; S Sollberg; R V Iozzo; R G Knowlton; J Uitto
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 2.  Use of basement membrane markers in tumour diagnosis.

Authors:  A J d'Ardenne
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

3.  Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes.

Authors:  J Ryynänen; S Sollberg; M G Parente; L C Chung; A M Christiano; J Uitto
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 4.  The bone morphogenetic protein 1/Tolloid-like metalloproteinases.

Authors:  Delana R Hopkins; Sunduz Keles; Daniel S Greenspan
Journal:  Matrix Biol       Date:  2007-05-18       Impact factor: 11.583

5.  SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa.

Authors:  Matthias Titeux; Valérie Pendaries; Maria A Zanta-Boussif; Audrey Décha; Nathalie Pironon; Laure Tonasso; José E Mejia; Agnes Brice; Olivier Danos; Alain Hovnanian
Journal:  Mol Ther       Date:  2010-05-18       Impact factor: 11.454

6.  Type II achondrogenesis-hypochondrogenesis: identification of abnormal type II collagen.

Authors:  M Godfrey; D W Hollister
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

7.  Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain.

Authors:  Nicholas P Morris; Carmen Peters; Ryan Montler; Hong-Ming Hu; Brendan D Curti; Walter J Urba; Andrew D Weinberg
Journal:  Mol Immunol       Date:  2007-03-19       Impact factor: 4.407

8.  Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis.

Authors:  David T Woodley; Yingping Hou; Sabrina Martin; Wei Li; Mei Chen
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

9.  Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure.

Authors:  Xinyi Wang; Pedram Ghasri; Mahsa Amir; Brian Hwang; Yingpin Hou; Michael Khalili; Michael Khilili; Andrew Lin; Douglas Keene; Jouni Uitto; David T Woodley; Mei Chen
Journal:  Mol Ther       Date:  2013-05-14       Impact factor: 11.454

10.  BMP1-like proteinases are essential to the structure and wound healing of skin.

Authors:  Alison M Muir; Dawiyat Massoudi; Ngon Nguyen; Douglas R Keene; Se-Jin Lee; David E Birk; Jeffrey M Davidson; M Peter Marinkovich; Daniel S Greenspan
Journal:  Matrix Biol       Date:  2016-06-27       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.